Saleem Ansari

Experience

• 

  Boehringer Ingelheim

  Mar 1985 - Nov 1985

  Medical Representative
• 

  Bristol-Myers Squibb

  Dec 1985 - Jan 2009

  ● Restructured the Sales Organization by creating Primary Care and Specialty Care Teams for Superior Customer Satisfaction and maximizing reach and frequency. ● Achieved increased productivity year on year basis by shifting focus on High Yielding towns and eliminating resources from low value brands. ● Champion’s Compliance Initiatives in sales force and marketing functions and rolled out the plans to both internal and external customers including sales force, medical community, distributors and government institutions for better understanding and ownership. ● Disproportionately allocate resources on growth drivers and manage low profit margin products through cyclic promotion. ● Engage formal training sessions for non conventional customer segments like (LHV) to provide disease management updates, helping them to alleviate sufferings of the women in rural areas. ● Revisited the Marketing Strategy in Export Markets which enabled doubling of sales in three years from (PKR 35 Million in 2008 to PKR 100 Million in 2010) in Afghanistan specifically. ● Rolled out a new Incentive Compensation Plan to motivate the sales force to achieve the growth objectives of the organization. Show less ● Transform and lead the Sales Team of 220 persons on Pan Pakistan basis. ● In market sales planning system was initiated to support supply chain to minimize stock outs and control DOI’s. ● Implement internal control standards to regulate distributor inventory to the globally accepted level. ● Maxipime was launched successfully in the market to establish the need of fourth generation Cephalosporin for HAP, VAP and Pediatric Infections. ● Launched Engran as a Premium Priced Antioxidant formula and positioned it as “Pollution Buster” with a very high acceptance by the Medical Community in a highly fragmented segment. ● Sales Force Effectiveness Initiatives were introduced to build Sales Force Competencies, Continuous Updation of Customer Database, Clear Segmentation, Right Targeting and Frequency for VHV/HV Customers and to ensure FLMs spend 70% time in the field for coaching MSRs. Show less Extensive marketing experience of 12 years at different positions, involving new product launches and managing key assets in Anti-infectives, Cardiovasculars , Vitamins , Respiratory , Dermatology, Virology and Oncology portfolios. Served as Brand Lead in preparing launch plans for anti-infective ( Duricef, Amikin, Precef, and Zanitrin ),Respiratory ( Quibron – T/SR) and effervescent ( UPSA brands) portfolios. Different positions with increasing responsibilities held during that period are listed below: ● Group Product Manager (Anti-infectives, Cardiovasculars and Effervescent portfolio) November 1999 to July 2002 ● Product Manager (Anti-infectives, Vitamins and Respiratory) April 1997 to November 1999 ● Assist. Product Manager (Anti-infectives, Dermatology)April 1993 to April 1997 ● Assoc. Product Manager (Anti-infectives)December 1990 to April 1993 Show less

  • Sr. Business Unit Director

    Jul 2007 - Jan 2009

  • Senior Sales Director

    Jul 2002 - Jul 2007

  • Brand Manager

    Dec 1990 - Jul 2002

  • Cardiovascular Focus Force Team

    Nov 1988 - Nov 1990

  • Medical Representative

    Dec 1985 - Nov 1988
• 

  GSK-Gebro Consumer Healthcare GmbH

  Feb 2009 - Aug 2010

  Senior Director Sales Marketing

  In this role, I was responsible for: ● Creating a compelling vision and translating it into objectives and plans; making decisions that support the organization’s strategy and mission; leveraging external sources to compliment internal capabilities; and aligning work and resources to reinforce priorities. ● Driving value of the Pakistan and Export business (Afghanistan, Sri Lanka and Bangladesh) with net sales of PKR 2.247 Billion, US$ Mil 28 through revenue growth and improved BUC by delivering key products’ sales and growth targets (Velosef PKR 1.12 Billion, Capoten PKR 142 Million, Engran PKR 38 Million, Maxipime PKR 32 Million, Motival PKR 125 Million, Princimox PKR 115 Million, Theragrans PKR 190 Million, Duricef PKR 96 Million and Taxol PKR 52 Million). ● Leading a team of 110 dynamic sales’ force ably supported by National Sales Manager, Group Product Manager, Product Manager, Training and Development Manager and Export Manager to achieve organizational goals in difficult times. ● Developing ideas and seeking alternatives that create value for patients and customers; focusing on continuous improvement and learning from success and mistakes; driving positive change; and taking appropriate and informed business risks. ● Working cooperatively across boundaries and matrix to achieve results; building and maintaining trust, promoting inclusion and respecting others, aligning individual and team objectives to deliver company strategy. ● Aggressively worked out the plan to win support from MoH for ‘Hardship Cases’ by engaging cross functional teams of finance, materials management and regulatory to win price revision for vitamins and other core products. Show less

• 

  Johnson & Johnson

  Aug 2011 - Nov 2015

  Health Care Compliance Officer Medical Devices, Consumer & Pharmaceuticals

  The core function revolves around: ● To lead and drive the health care compliance programs to ensure business practices and activities are in compliance with related J&J internal guidelines, local laws and regulations and anti-corruption laws, including FCPA - Foreign Corrupt Practices Act. Served as a strategic business partner ensuring the company culture of compliance is a natural element in day to day business. ● Champion of due diligence process with all Third Party Intermediaries (TPIs) interacting on behalf of J&J with HCPs and GOs. Ensure adequate training is on board for TPIs staff around FCPA compliance and Company processes. ● Run monitoring activities around high risk areas. Identify gaps and recommend action plans to improve the process ● SOPs implementation and training interacting HCPs value transfers and related activities within the organization. Show less

• 

  Roche

  Mar 2016 - Jul 2016

  Head Of Compliance

  Served as a strategic business partner by providing insights and solutions to the organization to meet business goals in a sustainable way.

• 

  Aspin Pharma Pvt. Ltd.

  Sept 2016 - Mar 2020

  Director Marketing and Sales

  Overall responsibility to drive sales and marketing functions by engaging 200 colleagues to drive PKR 3 Billion sales in 2019 and identifying new therapeutic areas to fuel growth:● Substantial increase in revenues (PKR 1.8 Billion to 3 Billion in 2019). An absolute increase of PKR 1.2 billion ● Motilium joined 1 Billion Rupee prestigious club in 2018 ● Leadership position attained in 5 major operating therapeutic categories ● Successfully launched branded generics ● Drive high performance culture ( PKR 1.3 million sales per rep) Show less

• 

  Pharmatec Pakistan (Private) Limited

  Oct 2020 - Jan 2021

  Director Marketing & Sales
• 

  NEXT Pharmaceutical Products Private Limited

  Aug 2021 - now

  Director Of Sales Marketing